Schaper Benz & Wise Investment Counsel Inc Bristol Myers Squibb CO Transaction History

Schaper Benz & Wise Investment Counsel Inc

$1.21 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	BUY	$63.71 - $70.74 $12,805 - $14,218	201 Added 6.21%	3,439 $219,000
Q1 2023 May 01, 2023	SELL	$65.71 - $74.53 $3,088 - $3,502	-47 Reduced 1.43%	3,238 $224,000
Q3 2022 Oct 17, 2022	SELL	$0.13 - $76.84 $164 - $97,048	-1,263 Reduced 27.77%	3,285 $234,000
Q1 2022 Apr 29, 2022	BUY	$61.48 - $73.72 $77,649 - $93,108	1,263 Added 38.45%	4,548 $332,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $176,174 - $205,378	3,285 New	3,285 $205,000
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $194,373 - $227,683	-3,285 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $189,675 - $214,937	3,285 New	3,285 $204,000
Q1 2020 May 04, 2020	SELL	$46.4 - $67.43 $154,883 - $225,081	-3,338 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$49.21 - $64.19 $164,262 - $214,266	3,338 New	3,338 $214,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $163,248 - $211,694	-3,348 Closed	0 $0
Q3 2018 Oct 19, 2018	BUY	$55.19 - $62.25 $184,776 - $208,413	3,348 New	3,348 $208,000
Q2 2018 Aug 06, 2018	SELL	$50.53 - $62.98 $169,174 - $210,857	-3,348 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $184,910 - $213,401	3,348	3,348 $213,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.15 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.36 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.5 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.52 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schaper Benz & Wise Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schaper Benz & Wise Investment Counsel Inc with notifications on news.

Account